Awareness of Biologically Confirmed HCV Among a Community Residing Sample of Drug Users in Baltimore City
Rent the article at a discountRent now
* Final gross prices may vary according to local VAT.Get Access
The present study sought to examine: (1) the prevalence and correlates of biologically confirmed Hepatitis C (HCV) and (2) the prevalence and correlates of prior HCV diagnosis and an unmet need for HCV treatment, among a community residing sample of drug users. The current study used a subset of HCV tested participants from the larger NEURO-HIV Epidemiologic Study from Baltimore, Maryland (Mage = 34.81, SD = 9.25; 46 % female). All participants were tested for HCV at baseline. Self-report was used to assess awareness of an HCV diagnosis and participation in treatment. Of the 782 participants tested for HCV, 19 % reported having received an HCV diagnosis in the past while 48 % tested positive for HCV. Only 6 % reported having received treatment for any form of hepatitis. Of those who tested HCV positive, 63 % reported never being diagnosed, and only 13 % received any treatment for HCV. We found that only 35 % of those who reported a prior HCV diagnosis received any treatment. The findings regarding lack of HCV awareness and diagnosis were considerable as expected. These deficits suggest that there are numerous gaps in patients’ knowledge and beliefs regarding HCV that may interfere at multiple steps along the path from diagnosis to treatment. This study clearly demonstrates that a critical need exists to improve public knowledge of HCV risk factors, the need for testing, and the availability of effective treatment.
- US Centers for Disease Control and Prevention. Hepatitis C information for health professionals–March 2011. http://www.cdc.gov/hepatitis/HCV/index.htm (Accessed 10 February 2013).
- El-Serag, H. B., & Rudolph, K. L. (2007). Hepatocellular carcinoma: epidemiology and molecular carcinogenesis. Gastroenterology, 7, 2557–2576. CrossRef
- Freeman, R. B., Steffick, D. E., Guidinger, M. K., Farmer, D. G., Berg, C. L., & Merion, R. M. (2006). Liver and intestine transplantation in the United States, 1997–2006. American Journal of Transplantation, 6, 956–976.
- Sanyal, A. J. (2010). The institute of medicine report on viral hepatitis: A call to action. Hepatology, 51, 727–728. CrossRef
- Eckman, M. H., Talal, A. H., Gordon, S. C., Schiff, E., & Sherman, K. E. (2013). Cost-effectiveness for chronic hepatitis C infection in the United States. Clinical Infectious Diseases. doi:10.1093/cid/cit069.
- Deuffic-Burban, S., & Yazdanpanah, Y. (2012). It’s time to change the paradigm for hepatitis C testing. Clinical Infectious Diseases, 54, 172–174. CrossRef
- Armstrong, G. L., Wasley, A., Simard, E. P., McQuillan, G. M., Kuhnert, W. L., & Alter, M. J. (2006). The prevalence of hepatitis C virus infection in the United States, 1999 through 2002. Annals of Internal Medicine, 144, 705–714. CrossRef
- McEwan, P., Ward, T., Yuan, Y., Kim, R., & L'Italian, J. (2013). The impact of timing and prioritisation on the cost-effectiveness of birth-cohort testing and treatment for hepatitis C virus in the U.S. Hepatology. doi:10.1002/hep.26304.
- Chak, E., Talal, A. H., Sherman, K. E., Schiff, E. R., & Saab, S. (2011). Hepatitis C virus infection in USA: An estimate of true prevalence. Liver International, 31, 1090–1101. CrossRef
- Mitchell, A. E., Colvin, H. M., & Palmer Beasley, R. (2010). Institute of Medicine recommendations for the prevention and control of hepatitis B and C. Hepatology, 51, 729–733. CrossRef
- Volk, M. L., Tocco, R., Saini, S., & Lok, A. S. (2009). Public health impact of antiviral therapy for hepatitis C in the United States. Hepatology, 50, 1750–1755. CrossRef
- Smith, B. D., Morgan, R. L., Beckett, G. A., et al. (2012). Recommendations for the identification of chronic hepatitis C virus infection among persons born during 1945–1965. MMWR Recomm Rep, 61, 1–32.
- US Centers for Disease Control and Prevention. Recommendations for prevention and control of hepatitis C virus [HCV] infection and HCV-related chronic disease. MMWR 1998; 47[No. RR-19]:1–33.
- Shehab, T. M., Sonnad, S. S., & Lok, A. S. (2001). Management of hepatitis C patients by primary care physicians in the USA: Results of a national survey. Journal of Viral Hepatitis, 8, 377–383. CrossRef
- Shehab, T. M., Orrego, M., Chunduri, R., & Lok, A. S. (2003). Identification and management of hepatitis C patients in primary care clinics. American Journal of Gastroenterology, 98, 639–644. CrossRef
- Cohen, M. H., Grey, D., Cook, J. A., et al. (2007). Awareness of hepatitis C infection among women with and at risk for HIV. Journal of General Internal Medicine, 22, 1689–1694. CrossRef
- Spradling, P. R., Rupp, L., Moorman, A. C., et al. (2012). Hepatitis B and C virus infection among 1.2 million persons with access to care: Factors associated with testing and infection prevalence. Clinical Infectious Diseases, 55, 1047–1055. CrossRef
- Vlahov, D., Anthony, J. C., Munoz, A., et al. (1991). The ALIVE study, a longitudinal study of HIV-1 infection in intravenous drug users: Description of methods and characteristics of participants. NIDA Research Monograph, 109, 75–100.
- Latkin, C., Mandell, W., Oziemkowska, M., et al. (1995). Using social network analysis to study patterns of drug-use among urban drug-users at high-risk for HIV-AIDS. Drug and Alcohol Dependence, 38, 1–9. CrossRef
- Hall, C. S., Charlebois, E. D., Hahn, J. A., Moss, A. R., & Bangsberg, D. R. (2004). Hepatitis C virus infection in San Francisco’s HIV-infected urban poor. Journal of General Internal Medicine, 19, 357–365. CrossRef
- Backus, L. I., Boothroyd, D., & Deyton, L. R. (2005). HIV, hepatitis C and HIV/hepatitis C virus co-infection in vulnerable populations. AIDS, 19, S13–S19. CrossRef
- Piccolo, P., Borg, L., Lin, A., Melia, D., Ho, A., & Kreek, M. J. (2002). Hepatitis C virus and human immunodeficiency virus-1 co-infection in former heroin addicts in methadone maintenance treatment. Journal of Addictive Diseases, 21, 55–56. CrossRef
- Mehta, S. H., Genberg, B. L., Astemborski, J., et al. (2008). Limited uptake of hepatitis C treatment among injection drug users. Journal of Community Health, 33, 126–133. CrossRef
- Leverence, R. R., Williams, R. L., Pace, W., et al. (2009). Context of clinical care: The case of hepatitis C in underserved communities—A report from the Primary Care Multiethnic Network (PRIME Net) Consortium. J Am Board Fam Med, 22, 638–646. CrossRef
- Drobnik, A., Judd, C., Banach, D., Egger, J., Konty, K., & Rude, E. (2011). Public health implications of rapid hepatitis C screening with an oral swab for community-based organizations serving high-risk populations. American Journal of Public Health, 101, 2151–2155. CrossRef
- Astell-Burt, T., Flowerdew, R., Boyle, P., & Dillon, J. (2012). Is travel-time to a specialist centre a risk factor for non-referral, non-attendance and loss to follow-up among patients with hepatitis C (HCV) infection? Social Science and Medicine, 75, 240–247. CrossRef
- Hickman, M., McDonald, T., Judd, A., et al. (2008). Increasing the uptake of hepatitis C virus testing among injecting drug users in specialist drug treatment and prison settings by using dried blood spots for diagnostic testing: a cluster randomized controlled trial. Journal of Viral Hepatitis, 15, 250–254. CrossRef
- Morrill, J. A., Shrestha, M., & Grant, R. W. (2005). Barriers to the treatment of hepatitis C: Patient, provider, and system factors. Journal of General Internal Medicine, 20, 754–758. CrossRef
- Zapta, R. (2010). Clinical approach to the patient with chronic hepatitis C infection and normal aminotransferases. Annals of Hepatology, 9, S72–S79.
- Sockalingam, S., & Abbey, S. E. (2009). Managing depression during hepatitis C treatment. Canadian Journal of Psychiatry, 54, 614–625.
- Holtzman, D., Barry, V., Ouellet, L. J., Des Jarlais, D. C., Vlahov, D., Golub, E. T., Garfein, R. S. (2009). The influence of needle exchange programs on injection risk behaviors and infection with hepatitis C virus among young injection drug users in select cities in the United States, 1994–2004 Preventive Medicine, 49, 68–73.
- Awareness of Biologically Confirmed HCV Among a Community Residing Sample of Drug Users in Baltimore City
Journal of Community Health
Volume 39, Issue 3 , pp 487-493
- Cover Date
- Print ISSN
- Online ISSN
- Springer US
- Additional Links
- Hepatitis C awareness
- Hepatitis C treatment
- Drug use
- Author Affiliations
- 1. Department of Clinical and Health Psychology, College of Public Health and Health Professions, University of Florida, 1225 Center Drive, Room 3146, Gainesville, FL, 32611, USA
- 2. Department of Clinical and Health Psychology, University of Florida, 1225 Center Drive, Room 3180, Gainesville, FL, 32611, USA
- 4. Department of Clinical and Health Psychology, University of Florida, 1225 Center Drive, Room 3146, Gainesville, FL, 32611, USA
- 3. Department of Epidemiology, University of Florida, 1225 Center Drive, Room 3110, Gainesville, FL, 32611, USA
- 5. Department of Clinical and Health Psychology, University of Florida, 1225 Center Drive, Room 3151, Gainesville, FL, 32611, USA